# BETRF (Betterlife Pharma Inc.) - SEC EDGAR Financial Statements

> Betterlife Pharma Inc. reported C$225K in total assets and a net loss of C$3.62M through January 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BETRF
- Markdown: https://convexityos.com/fundamentals/BETRF.md
- SEC CIK: 0001464165
- Reporting currency: CAD
- Latest filing period: January 31, 2025
- Last synced: Nov 20, 2026, 05:50 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001464165&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Jan 31, 2025 |
| Operating Income | FY 2025 | -C$5.00M | Operating profit |
| Net Income | FY 2025 | -C$3.62M | GAAP bottom line |
| Diluted EPS | FY 2025 | -C$0.03 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jan 31, 2025 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2015 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | C$424K | C$571K | C$2.68M | C$5.42M | C$285K | C$64K | C$430K | C$91K | -- | -- |
| Selling, General & Admin | C$260K | C$272K | C$404K | -- | -- | -- | C$2.38M | -- | -- | -- |
| Total Operating Expenses | C$5.00M | C$3.24M | C$9.46M | C$10.21M | C$7.92M | C$9.34M | C$6.84M | C$1.35M | C$131K | C$77K |
| **Operating Income** | -C$5.00M | -C$3.24M | -C$9.46M | -- | -- | -- | -C$6.84M | -C$1.35M | -- | -- |
| **EBITDA** | -C$5.00M | -C$3.24M | -C$9.44M | -- | -- | -- | -C$5.94M | -C$1.32M | -- | -- |
| Interest Income | -- | -- | -- | -- | C$265 | C$4.5K | -- | -- | -- | -- |
| Interest Expense | C$165K | C$46K | C$11K | C$52K | C$7.0K | C$48K | C$391K | C$35K | C$72K | C$35K |
| Income Before Tax | -- | -C$2.90M | -C$9.37M | -C$11.99M | -C$36.35M | -C$19.59M | -- | -- | -- | -- |
| **Net Income** | -C$3.62M | -C$2.90M | -C$9.37M | -C$12.16M | -C$36.35M | -C$19.59M | -C$9.15M | -C$42K | -C$1.26M | -C$754K |
| Basic EPS | -- | -- | -- | -- | -- | -- | -C$0.10 | C$0.00 | -C$0.11 | -C$0.20 |
| **Diluted EPS** | -C$0.03 | -C$0.03 | -C$0.10 | -C$0.16 | -C$1.34 | -C$1.30 | -C$0.10 | C$0.00 | -C$0.11 | -C$0.20 |
| Basic Shares Outstanding | 123.9M | 109.3M | 86.6M | 75.5M | 27.0M | 15.0M | 90.2M | 79.9M | 11.6M | 4.8M |
| Diluted Shares Outstanding | 123.9M | 109.3M | 86.6M | 438.1K | 0 | 0 | 90.2M | 79.9M | -- | -- |

### Income Statement (Quarterly)

| Line Item | Apr 2019 | Apr 2018 | Oct 2015 | Jul 2015 | Apr 2015 | Jan 2015 | Oct 2014 | Jul 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | C$59K | C$109K | -- | -- | -- | -- | -- | -- |
| Selling, General & Admin | -- | C$965K | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | C$1.66M | C$1.88M | C$10K | C$2.94M | C$1.45M | C$65K | C$28K | C$30K |
| **Operating Income** | -C$1.66M | -C$1.88M | -- | -- | -- | -- | -- | -- |
| Interest Expense | C$240K | C$201K | -- | -- | -- | C$44K | C$10K | C$9.5K |
| **Net Income** | -C$1.87M | -C$2.10M | -C$10K | -C$2.94M | -C$1.46M | -C$1.14M | -C$168K | -C$36K |
| Basic EPS | -C$0.02 | -C$0.03 | C$0.00 | -C$0.04 | -C$0.02 | -- | C$0.00 | C$0.00 |
| **Diluted EPS** | -C$0.02 | -C$0.03 | C$0.00 | -C$0.04 | -C$0.02 | -- | C$0.00 | C$0.00 |
| Basic Shares Outstanding | 99.5M | 86.2M | 85.6M | 78.9M | 72.6M | -- | 11.6M | 11.6M |
| Diluted Shares Outstanding | 99.5M | 86.2M | 85.6M | 78.9M | -- | -- | -- | 11.6M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2015 | FY 2014 | FY 2013 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | C$174K | C$155K | C$75K | C$79K | C$1.1K | C$1.0K | C$475 |
| **Cash & Short-Term Investments** | -- | -- | -- | C$174K | C$155K | C$75K | C$79K | C$1.1K | C$1.0K | C$475 |
| Accounts Receivable, Net | C$12K | C$40K | C$17K | C$325K | C$520K | -- | -- | C$126 | C$5.3K | -- |
| **Total Current Assets** | -- | -- | -- | C$1.14M | C$1.33M | C$242K | C$183K | C$1.2K | C$6.3K | C$4.7K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | C$4.2K | -- | C$417 | C$872 | -- |
| Intangible Assets | -- | -- | -- | -- | -- | C$9.29M | C$288K | -- | -- | -- |
| **Total Non-Current Assets** | -- | -- | -- | C$18K | C$6.9K | C$8.35M | C$288K | C$417 | C$872 | C$1.3K |
| **Total Assets** | C$225K | C$325K | C$75K | C$1.16M | C$1.34M | C$8.60M | C$472K | C$1.6K | C$7.2K | C$6.1K |
| Short-Term Debt | -- | C$50K | C$80K | C$40K | C$0 | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | C$158K | -- | -- | -- | -- |
| **Total Current Liabilities** | C$7.54M | C$7.35M | C$7.15M | C$4.14M | C$5.85M | C$5.09M | -- | C$71K | C$729K | C$662K |
| Long-Term Debt | -- | C$49K | C$0 | C$35K | C$0 | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | C$49K | C$673K | C$461K | C$899K | C$132K | C$0 | -- | C$0 | C$29K | C$18K |
| **Total Liabilities** | C$7.59M | C$8.02M | C$7.61M | C$5.04M | C$5.98M | C$5.09M | C$528K | C$71K | C$758K | C$681K |
| **Total Debt (incl. Leases)** | -- | C$99K | C$80K | C$75K | C$0 | C$1.78M | -- | -- | -- | -- |
| Common Stock | C$79.97M | C$78.46M | C$76.57M | C$75.38M | C$63.67M | C$21.34M | C$10.05M | C$3.83M | C$1.67M | C$1.09M |
| Retained Earnings | -C$118.6M | -C$115.1M | -C$112.2M | -C$103.2M | -C$91.01M | -C$34.96M | -C$25.82M | -C$4.17M | -C$2.91M | -- |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | C$123K | -- | -- | -- | -- |
| **Total Stockholders' Equity** | -C$7.36M | -C$7.70M | -C$7.53M | -C$3.88M | -C$4.61M | C$3.50M | -C$56K | -C$69K | -C$751K | -C$675K |
| Total Equity | -C$7.36M | -C$7.70M | -C$7.53M | -C$3.88M | -C$4.61M | C$3.50M | -C$56K | -C$69K | -C$751K | -C$675K |

### Balance Sheet (Quarterly)

| Line Item | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Apr 2019 | Jan 2019 | Jan 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | C$174K | C$155K | C$45K | C$75K | C$79K |
| **Cash & Short-Term Investments** | -- | -- | -- | C$174K | C$155K | C$45K | C$75K | C$79K |
| Accounts Receivable, Net | C$12K | C$40K | C$17K | C$325K | C$520K | -- | -- | -- |
| **Total Current Assets** | -- | -- | -- | C$1.14M | C$1.33M | C$194K | C$242K | C$183K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | C$4.2K | -- |
| Intangible Assets | -- | -- | -- | -- | -- | C$8.26M | C$9.29M | C$288K |
| **Total Non-Current Assets** | -- | -- | -- | C$18K | C$6.9K | C$9.36M | C$8.35M | C$288K |
| **Total Assets** | C$225K | C$325K | C$75K | C$1.16M | C$1.34M | C$9.55M | C$8.60M | C$472K |
| Short-Term Debt | -- | C$50K | C$80K | C$40K | C$0 | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | C$158K | -- |
| **Total Current Liabilities** | C$7.54M | C$7.35M | C$7.15M | C$4.14M | C$5.85M | C$5.32M | C$5.09M | -- |
| Long-Term Debt | -- | C$49K | C$0 | C$35K | C$0 | -- | -- | -- |
| **Total Non-Current Liabilities** | C$49K | C$673K | C$461K | C$899K | C$132K | C$864K | C$0 | -- |
| **Total Liabilities** | C$7.59M | C$8.02M | C$7.61M | C$5.04M | C$5.98M | C$6.18M | C$5.09M | C$528K |
| **Total Debt (incl. Leases)** | -- | C$99K | C$80K | C$75K | C$0 | C$1.11M | C$1.78M | -- |
| Common Stock | C$79.97M | C$78.46M | C$76.57M | C$75.38M | C$63.67M | C$22.95M | C$21.34M | C$10.05M |
| Retained Earnings | -C$118.6M | -C$115.1M | -C$112.2M | -C$103.2M | -C$91.01M | -C$36.86M | -C$34.96M | -C$25.82M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | C$245K | C$123K | -- |
| **Total Stockholders' Equity** | -C$7.36M | -C$7.70M | -C$7.53M | -C$3.88M | -C$4.61M | C$3.37M | C$3.50M | -C$56K |
| Total Equity | -C$7.36M | -C$7.70M | -C$7.53M | -C$3.88M | -C$4.61M | C$3.37M | C$3.50M | -C$56K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2015 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -C$3.62M | -C$2.90M | -C$9.37M | -C$12.16M | -C$36.35M | -C$19.59M | -C$9.15M | -C$42K | -C$1.26M | -C$754K |
| Depreciation & Amortization | C$0 | C$0 | C$18K | C$18K | C$18K | C$986K | C$901K | C$31K | C$455 | C$455 |
| Stock-Based Compensation | C$2.05M | C$500K | C$951K | C$1.23M | -- | -- | C$32K | C$64K | -- | -- |
| Change in Receivables | C$28K | -C$22K | C$310K | C$181K | -- | -- | -- | -- | -- | -- |
| Change in Payables | -- | -C$702K | C$2.21M | -C$1.16M | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -C$2.02M | -C$2.47M | -C$1.50M | -C$11.20M | -C$7.16M | -C$7.88M | -C$4.98M | -C$562K | -C$53K | -C$27K |
| Capital Expenditure | -- | -- | -- | -- | C$10K | C$543K | -- | -- | -- | -- |
| **Free Cash Flow** | -- | -- | -- | -- | -C$7.15M | -C$7.34M | -- | -- | -- | -- |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | C$2.8K | -- | -- | -- |
| **Investing Cash Flow** | -- | -- | -- | -- | -C$72K | -C$1.14M | -C$851K | -- | -- | -- |
| Common Stock Issued | C$705K | C$2.20M | C$647K | -- | -- | -- | -- | C$410K | -- | -- |
| **Financing Cash Flow** | C$1.99M | C$2.50M | C$1.34M | C$11.23M | C$4.09M | C$12.23M | C$5.83M | C$457K | C$53K | C$28K |
| **Net Change in Cash** | -C$29K | C$29K | -C$165K | C$19K | -C$3.13M | C$3.21M | -- | -- | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Apr 2019 | Apr 2018 | Oct 2015 | Jul 2015 | Apr 2015 | Jan 2015 | Oct 2014 | Jul 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -C$1.87M | -C$2.10M | -C$10K | -C$2.94M | -C$1.46M | -C$1.14M | -C$168K | -C$36K |
| Depreciation & Amortization | -- | -- | C$113 | C$114 | C$114 | C$114 | C$114 | C$114 |
| Stock-Based Compensation | C$5.9K | C$35K | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -C$568K | -C$2.42M | -C$82K | -C$25K | -C$16K | -C$45K | -C$11K | C$4.7K |
| Acquisitions, Net | -- | -C$428K | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -- | -C$426K | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | C$526K | C$4.68M | C$0 | C$261K | C$49K | -- | -- | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2015 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -261.7% | -- | -- | -- |
| Return on Assets (ROA) | -1610.0% | -892.5% | -12542.7% | -1047.0% | -2720.0% | -- | -106.4% | -9.0% | -78077.5% | -10518.7% |
| Current Ratio | -- | -- | -- | 0.28x | 0.23x | -- | 0.05x | -- | 0.02x | 0.01x |
| Quick Ratio | -- | -- | -- | 0.12x | 0.12x | -- | 0.01x | -- | 0.02x | 0.01x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | 0.51x | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -- | -- | -320.8% |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -105.6% | -- | -- |
| 10Y Net Income / Share Growth | -- | -- | -1234.3% | -485.7% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Apr 2019 | Apr 2018 | Oct 2015 | Jul 2015 | Apr 2015 | Jan 2015 | Oct 2014 | Jul 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -8639.5% | -3169.2% | -- | -- | -- | -- |
| Return on Assets (ROA) | -- | -- | -2665.1% | -2098.9% | -8010.6% | -78077.5% | -2133.2% | -5233.8% |
| Current Ratio | 0.04x | -- | -- | -- | -- | 0.02x | -- | 0.02x |
| Quick Ratio | 0.01x | -- | -- | -- | -- | 0.02x | -- | 0.01x |
| Debt to Equity | 0.33x | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -1705.9% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -300.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -627.0% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
